
|Articles|October 1, 2002
Supplements and Featured Publications
- Cardiorenal Differences Among NSAIDs and Coxibs: Real-World Experience
- Volume 8
- Issue 15 Suppl
Differences Between COX-2-Specific Inhibitors: Clinical and Economic Implications
Author(s)Edmund H. Sonnenblick, MD
Advertisement
Articles in this issue
over 23 years ago
Participating FacultyNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
As Cencora Closes With OneOncology, Patton Says Terms Show “Trust”
2
TrumpRx Launch Brings Savings—and Uncertainty
3
Exploring Identity, Appearance Experiences Among Patients With Alopecia
4
Benefits, Tradeoffs of Medically Integrated Dispensing in Oncology Care: Katherine Tobon, PharmD, BCOP
5









